nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR2C—type 2 diabetes mellitus	0.27	1	CbGaD
Cyproheptadine—UGT1A3—Irbesartan—type 2 diabetes mellitus	0.107	0.238	CbGbCtD
Cyproheptadine—UGT1A3—Losartan—type 2 diabetes mellitus	0.0691	0.154	CbGbCtD
Cyproheptadine—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0679	0.151	CbGbCtD
Cyproheptadine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0607	0.135	CbGbCtD
Cyproheptadine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0395	0.0878	CbGbCtD
Cyproheptadine—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0372	0.0827	CbGbCtD
Cyproheptadine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0356	0.0791	CbGbCtD
Cyproheptadine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0328	0.0729	CbGbCtD
Cyproheptadine—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.0035	0.132	CbGeAlD
Cyproheptadine—HTR2A—arteriole—type 2 diabetes mellitus	0.0033	0.124	CbGeAlD
Cyproheptadine—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00235	0.0885	CbGeAlD
Cyproheptadine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0021	0.0791	CbGeAlD
Cyproheptadine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00141	0.0532	CbGeAlD
Cyproheptadine—SLC6A2—nerve—type 2 diabetes mellitus	0.00132	0.0498	CbGeAlD
Cyproheptadine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00131	0.0492	CbGeAlD
Cyproheptadine—DRD2—nerve—type 2 diabetes mellitus	0.00121	0.0453	CbGeAlD
Cyproheptadine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00102	0.0384	CbGeAlD
Cyproheptadine—UGT1A3—liver—type 2 diabetes mellitus	0.00102	0.0383	CbGeAlD
Cyproheptadine—HTR2A—artery—type 2 diabetes mellitus	0.000802	0.0302	CbGeAlD
Cyproheptadine—HTR2A—nerve—type 2 diabetes mellitus	0.000796	0.0299	CbGeAlD
Cyproheptadine—HTR2A—endothelium—type 2 diabetes mellitus	0.000678	0.0255	CbGeAlD
Cyproheptadine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000577	0.0217	CbGeAlD
Cyproheptadine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000525	0.0197	CbGeAlD
Cyproheptadine—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000522	0.0196	CbGeAlD
Cyproheptadine—DRD2—retina—type 2 diabetes mellitus	0.0005	0.0188	CbGeAlD
Cyproheptadine—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000497	0.0187	CbGeAlD
Cyproheptadine—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000468	0.0176	CbGeAlD
Cyproheptadine—HTR2B—adipose tissue—type 2 diabetes mellitus	0.00046	0.0173	CbGeAlD
Cyproheptadine—CHRM3—kidney—type 2 diabetes mellitus	0.00046	0.0173	CbGeAlD
Cyproheptadine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000414	0.0156	CbGeAlD
Cyproheptadine—HTR2A—retina—type 2 diabetes mellitus	0.00033	0.0124	CbGeAlD
Cyproheptadine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000294	0.0111	CbGeAlD
Cyproheptadine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000279	0.0105	CbGeAlD
Cyproheptadine—HTR2A—kidney—type 2 diabetes mellitus	0.000273	0.0103	CbGeAlD
Cyproheptadine—Metixene—HTR2C—type 2 diabetes mellitus	0.000252	0.0802	CrCbGaD
Cyproheptadine—Azatadine—CYP3A4—type 2 diabetes mellitus	0.000216	0.0687	CrCbGaD
Cyproheptadine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000215	0.00136	CcSEcCtD
Cyproheptadine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000214	0.00135	CcSEcCtD
Cyproheptadine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000213	0.00135	CcSEcCtD
Cyproheptadine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000213	0.00135	CcSEcCtD
Cyproheptadine—Chills—Irbesartan—type 2 diabetes mellitus	0.000212	0.00135	CcSEcCtD
Cyproheptadine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000212	0.00134	CcSEcCtD
Cyproheptadine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000212	0.00134	CcSEcCtD
Cyproheptadine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000211	0.00134	CcSEcCtD
Cyproheptadine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000211	0.00134	CcSEcCtD
Cyproheptadine—Palpitations—Orlistat—type 2 diabetes mellitus	0.000209	0.00133	CcSEcCtD
Cyproheptadine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000209	0.00132	CcSEcCtD
Cyproheptadine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000209	0.00132	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000208	0.00132	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000208	0.00132	CcSEcCtD
Cyproheptadine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000208	0.00132	CcSEcCtD
Cyproheptadine—Tinnitus—Losartan—type 2 diabetes mellitus	0.000208	0.00132	CcSEcCtD
Cyproheptadine—Jaundice—Ramipril—type 2 diabetes mellitus	0.000207	0.00131	CcSEcCtD
Cyproheptadine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000206	0.00131	CcSEcCtD
Cyproheptadine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000206	0.00131	CcSEcCtD
Cyproheptadine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00131	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000206	0.0013	CcSEcCtD
Cyproheptadine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000206	0.0013	CcSEcCtD
Cyproheptadine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000206	0.0013	CcSEcCtD
Cyproheptadine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000205	0.0013	CcSEcCtD
Cyproheptadine—Tremor—Metformin—type 2 diabetes mellitus	0.000204	0.0013	CcSEcCtD
Cyproheptadine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000204	0.00129	CcSEcCtD
Cyproheptadine—Tension—Irbesartan—type 2 diabetes mellitus	0.000202	0.00128	CcSEcCtD
Cyproheptadine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000202	0.00128	CcSEcCtD
Cyproheptadine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.0002	0.00127	CcSEcCtD
Cyproheptadine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000199	0.00126	CcSEcCtD
Cyproheptadine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000198	0.00126	CcSEcCtD
Cyproheptadine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000197	0.00125	CcSEcCtD
Cyproheptadine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000196	0.00124	CcSEcCtD
Cyproheptadine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000196	0.00124	CcSEcCtD
Cyproheptadine—Syncope—Metformin—type 2 diabetes mellitus	0.000196	0.00124	CcSEcCtD
Cyproheptadine—Oedema—Valsartan—type 2 diabetes mellitus	0.000196	0.00124	CcSEcCtD
Cyproheptadine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000195	0.00124	CcSEcCtD
Cyproheptadine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000195	0.00124	CcSEcCtD
Cyproheptadine—Rash—Glipizide—type 2 diabetes mellitus	0.000194	0.00123	CcSEcCtD
Cyproheptadine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000194	0.00123	CcSEcCtD
Cyproheptadine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000194	0.00123	CcSEcCtD
Cyproheptadine—Oedema—Orlistat—type 2 diabetes mellitus	0.000193	0.00122	CcSEcCtD
Cyproheptadine—Headache—Glipizide—type 2 diabetes mellitus	0.000193	0.00122	CcSEcCtD
Cyproheptadine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000193	0.00122	CcSEcCtD
Cyproheptadine—Palpitations—Metformin—type 2 diabetes mellitus	0.000193	0.00122	CcSEcCtD
Cyproheptadine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000193	0.00122	CcSEcCtD
Cyproheptadine—Shock—Valsartan—type 2 diabetes mellitus	0.000192	0.00122	CcSEcCtD
Cyproheptadine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000192	0.00122	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000191	0.00121	CcSEcCtD
Cyproheptadine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000191	0.00121	CcSEcCtD
Cyproheptadine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000191	0.00121	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.00019	0.0605	CrCbGaD
Cyproheptadine—Tension—Losartan—type 2 diabetes mellitus	0.00019	0.00121	CcSEcCtD
Cyproheptadine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00019	0.0012	CcSEcCtD
Cyproheptadine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000189	0.0012	CcSEcCtD
Cyproheptadine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000189	0.0012	CcSEcCtD
Cyproheptadine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000189	0.0012	CcSEcCtD
Cyproheptadine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000188	0.00119	CcSEcCtD
Cyproheptadine—Nervousness—Losartan—type 2 diabetes mellitus	0.000188	0.00119	CcSEcCtD
Cyproheptadine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000187	0.00119	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000187	0.00118	CcSEcCtD
Cyproheptadine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000186	0.00118	CcSEcCtD
Cyproheptadine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000186	0.00118	CcSEcCtD
Cyproheptadine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000185	0.00117	CcSEcCtD
Cyproheptadine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000185	0.00117	CcSEcCtD
Cyproheptadine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000185	0.00117	CcSEcCtD
Cyproheptadine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00117	CcSEcCtD
Cyproheptadine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000184	0.00116	CcSEcCtD
Cyproheptadine—Nausea—Glipizide—type 2 diabetes mellitus	0.000183	0.00116	CcSEcCtD
Cyproheptadine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000183	0.00116	CcSEcCtD
Cyproheptadine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000183	0.00116	CcSEcCtD
Cyproheptadine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000183	0.00116	CcSEcCtD
Cyproheptadine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000182	0.00115	CcSEcCtD
Cyproheptadine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000182	0.00115	CcSEcCtD
Cyproheptadine—Tremor—Losartan—type 2 diabetes mellitus	0.000182	0.00115	CcSEcCtD
Cyproheptadine—Rash—Glimepiride—type 2 diabetes mellitus	0.000181	0.00115	CcSEcCtD
Cyproheptadine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000181	0.00115	CcSEcCtD
Cyproheptadine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000181	0.00115	CcSEcCtD
Cyproheptadine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00115	CcSEcCtD
Cyproheptadine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00018	0.00114	CcSEcCtD
Cyproheptadine—Headache—Glimepiride—type 2 diabetes mellitus	0.00018	0.00114	CcSEcCtD
Cyproheptadine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000179	0.00114	CcSEcCtD
Cyproheptadine—Agitation—Losartan—type 2 diabetes mellitus	0.000178	0.00113	CcSEcCtD
Cyproheptadine—Oedema—Metformin—type 2 diabetes mellitus	0.000178	0.00113	CcSEcCtD
Cyproheptadine—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000178	0.00113	CcSEcCtD
Cyproheptadine—Carbamazepine—ABCC2—type 2 diabetes mellitus	0.000178	0.0565	CrCbGaD
Cyproheptadine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000177	0.00112	CcSEcCtD
Cyproheptadine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000177	0.00112	CcSEcCtD
Cyproheptadine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000176	0.00111	CcSEcCtD
Cyproheptadine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000175	0.00111	CcSEcCtD
Cyproheptadine—Shock—Metformin—type 2 diabetes mellitus	0.000175	0.00111	CcSEcCtD
Cyproheptadine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000175	0.00111	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000174	0.00111	CcSEcCtD
Cyproheptadine—Vertigo—Losartan—type 2 diabetes mellitus	0.000174	0.0011	CcSEcCtD
Cyproheptadine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000174	0.0011	CcSEcCtD
Cyproheptadine—Syncope—Losartan—type 2 diabetes mellitus	0.000174	0.0011	CcSEcCtD
Cyproheptadine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000174	0.0011	CcSEcCtD
Cyproheptadine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000173	0.0011	CcSEcCtD
Cyproheptadine—HTR2A—liver—type 2 diabetes mellitus	0.000172	0.00648	CbGeAlD
Cyproheptadine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000172	0.00109	CcSEcCtD
Cyproheptadine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000172	0.00109	CcSEcCtD
Cyproheptadine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00109	CcSEcCtD
Cyproheptadine—Palpitations—Losartan—type 2 diabetes mellitus	0.000171	0.00109	CcSEcCtD
Cyproheptadine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000171	0.00108	CcSEcCtD
Cyproheptadine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00017	0.00108	CcSEcCtD
Cyproheptadine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00017	0.00108	CcSEcCtD
Cyproheptadine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00017	0.00108	CcSEcCtD
Cyproheptadine—Asthenia—Glyburide—type 2 diabetes mellitus	0.00017	0.00108	CcSEcCtD
Cyproheptadine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00017	0.00108	CcSEcCtD
Cyproheptadine—Anorexia—Metformin—type 2 diabetes mellitus	0.00017	0.00108	CcSEcCtD
Cyproheptadine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000169	0.00107	CcSEcCtD
Cyproheptadine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000169	0.00107	CcSEcCtD
Cyproheptadine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000168	0.00107	CcSEcCtD
Cyproheptadine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000168	0.00106	CcSEcCtD
Cyproheptadine—Constipation—Valsartan—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Cyproheptadine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000167	0.00106	CcSEcCtD
Cyproheptadine—Hypotension—Metformin—type 2 diabetes mellitus	0.000166	0.00105	CcSEcCtD
Cyproheptadine—Shock—Irbesartan—type 2 diabetes mellitus	0.000165	0.00105	CcSEcCtD
Cyproheptadine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000165	0.00105	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000165	0.00104	CcSEcCtD
Cyproheptadine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000164	0.00104	CcSEcCtD
Cyproheptadine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00104	CcSEcCtD
Cyproheptadine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00104	CcSEcCtD
Cyproheptadine—Tension—Ramipril—type 2 diabetes mellitus	0.000163	0.00103	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000162	0.00103	CcSEcCtD
Cyproheptadine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00103	CcSEcCtD
Cyproheptadine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000162	0.00103	CcSEcCtD
Cyproheptadine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000161	0.00102	CcSEcCtD
Cyproheptadine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00016	0.00102	CcSEcCtD
Cyproheptadine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00016	0.00101	CcSEcCtD
Cyproheptadine—Confusional state—Losartan—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Cyproheptadine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000159	0.00101	CcSEcCtD
Cyproheptadine—Somnolence—Metformin—type 2 diabetes mellitus	0.000158	0.001	CcSEcCtD
Cyproheptadine—Oedema—Losartan—type 2 diabetes mellitus	0.000158	0.001	CcSEcCtD
Cyproheptadine—Mianserin—ADRA2A—type 2 diabetes mellitus	0.000157	0.05	CrCbGaD
Cyproheptadine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000157	0.000995	CcSEcCtD
Cyproheptadine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000157	0.000994	CcSEcCtD
Cyproheptadine—Tremor—Ramipril—type 2 diabetes mellitus	0.000156	0.000987	CcSEcCtD
Cyproheptadine—Shock—Losartan—type 2 diabetes mellitus	0.000156	0.000986	CcSEcCtD
Cyproheptadine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000155	0.000985	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000155	0.000982	CcSEcCtD
Cyproheptadine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000155	0.000981	CcSEcCtD
Cyproheptadine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000154	0.000979	CcSEcCtD
Cyproheptadine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000154	0.000976	CcSEcCtD
Cyproheptadine—Fatigue—Metformin—type 2 diabetes mellitus	0.000154	0.000973	CcSEcCtD
Cyproheptadine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000154	0.000973	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000153	0.000969	CcSEcCtD
Cyproheptadine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000153	0.000968	CcSEcCtD
Cyproheptadine—Agitation—Ramipril—type 2 diabetes mellitus	0.000153	0.000968	CcSEcCtD
Cyproheptadine—Constipation—Metformin—type 2 diabetes mellitus	0.000152	0.000965	CcSEcCtD
Cyproheptadine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000151	0.000957	CcSEcCtD
Cyproheptadine—Anorexia—Losartan—type 2 diabetes mellitus	0.000151	0.000956	CcSEcCtD
Cyproheptadine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000151	0.000955	CcSEcCtD
Cyproheptadine—Rash—Glyburide—type 2 diabetes mellitus	0.000149	0.000947	CcSEcCtD
Cyproheptadine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000149	0.000947	CcSEcCtD
Cyproheptadine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000149	0.000947	CcSEcCtD
Cyproheptadine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000149	0.000946	CcSEcCtD
Cyproheptadine—Syncope—Ramipril—type 2 diabetes mellitus	0.000149	0.000945	CcSEcCtD
Cyproheptadine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000149	0.000943	CcSEcCtD
Cyproheptadine—Headache—Glyburide—type 2 diabetes mellitus	0.000148	0.000941	CcSEcCtD
Cyproheptadine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000148	0.000938	CcSEcCtD
Cyproheptadine—Hypotension—Losartan—type 2 diabetes mellitus	0.000148	0.000937	CcSEcCtD
Cyproheptadine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000147	0.000931	CcSEcCtD
Cyproheptadine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000147	0.00093	CcSEcCtD
Cyproheptadine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000146	0.000926	CcSEcCtD
Cyproheptadine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000146	0.000926	CcSEcCtD
Cyproheptadine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000146	0.000923	CcSEcCtD
Cyproheptadine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000145	0.000918	CcSEcCtD
Cyproheptadine—Mianserin—HTR2C—type 2 diabetes mellitus	0.000145	0.0461	CrCbGaD
Cyproheptadine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000144	0.000913	CcSEcCtD
Cyproheptadine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000144	0.000911	CcSEcCtD
Cyproheptadine—Insomnia—Losartan—type 2 diabetes mellitus	0.000143	0.000907	CcSEcCtD
Cyproheptadine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000142	0.0009	CcSEcCtD
Cyproheptadine—Urticaria—Metformin—type 2 diabetes mellitus	0.000141	0.000897	CcSEcCtD
Cyproheptadine—Nausea—Glyburide—type 2 diabetes mellitus	0.000141	0.000893	CcSEcCtD
Cyproheptadine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000141	0.000892	CcSEcCtD
Cyproheptadine—Somnolence—Losartan—type 2 diabetes mellitus	0.000141	0.000891	CcSEcCtD
Cyproheptadine—Asthenia—Valsartan—type 2 diabetes mellitus	0.00014	0.000889	CcSEcCtD
Cyproheptadine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000139	0.000883	CcSEcCtD
Cyproheptadine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000139	0.000879	CcSEcCtD
Cyproheptadine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000138	0.000878	CcSEcCtD
Cyproheptadine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000137	0.000872	CcSEcCtD
Cyproheptadine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000137	0.000867	CcSEcCtD
Cyproheptadine—Fatigue—Losartan—type 2 diabetes mellitus	0.000136	0.000864	CcSEcCtD
Cyproheptadine—Oedema—Ramipril—type 2 diabetes mellitus	0.000136	0.00086	CcSEcCtD
Cyproheptadine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000135	0.000858	CcSEcCtD
Cyproheptadine—Constipation—Losartan—type 2 diabetes mellitus	0.000135	0.000857	CcSEcCtD
Cyproheptadine—Rash—Gliclazide—type 2 diabetes mellitus	0.000134	0.000851	CcSEcCtD
Cyproheptadine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000134	0.00085	CcSEcCtD
Cyproheptadine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000134	0.000848	CcSEcCtD
Cyproheptadine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000134	0.000846	CcSEcCtD
Cyproheptadine—Shock—Ramipril—type 2 diabetes mellitus	0.000133	0.000846	CcSEcCtD
Cyproheptadine—Headache—Gliclazide—type 2 diabetes mellitus	0.000133	0.000845	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000133	0.000842	CcSEcCtD
Cyproheptadine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000132	0.000839	CcSEcCtD
Cyproheptadine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000132	0.000838	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000131	0.000831	CcSEcCtD
Cyproheptadine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00013	0.000826	CcSEcCtD
Cyproheptadine—Nortriptyline—HTR2C—type 2 diabetes mellitus	0.000129	0.0412	CrCbGaD
Cyproheptadine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000129	0.00082	CcSEcCtD
Cyproheptadine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000129	0.000819	CcSEcCtD
Cyproheptadine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000128	0.00081	CcSEcCtD
Cyproheptadine—Asthenia—Metformin—type 2 diabetes mellitus	0.000128	0.00081	CcSEcCtD
Cyproheptadine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000127	0.000803	CcSEcCtD
Cyproheptadine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000126	0.000801	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	0.000126	0.0401	CrCbGaD
Cyproheptadine—Urticaria—Losartan—type 2 diabetes mellitus	0.000126	0.000796	CcSEcCtD
Cyproheptadine—Loxapine—ADRA2A—type 2 diabetes mellitus	0.000125	0.0398	CrCbGaD
Cyproheptadine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000124	0.000788	CcSEcCtD
Cyproheptadine—Rash—Valsartan—type 2 diabetes mellitus	0.000123	0.000782	CcSEcCtD
Cyproheptadine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000123	0.000781	CcSEcCtD
Cyproheptadine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000123	0.000779	CcSEcCtD
Cyproheptadine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000123	0.000778	CcSEcCtD
Cyproheptadine—Headache—Valsartan—type 2 diabetes mellitus	0.000123	0.000777	CcSEcCtD
Cyproheptadine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000122	0.000772	CcSEcCtD
Cyproheptadine—Rash—Orlistat—type 2 diabetes mellitus	0.000122	0.000772	CcSEcCtD
Cyproheptadine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000122	0.000772	CcSEcCtD
Cyproheptadine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000122	0.000772	CcSEcCtD
Cyproheptadine—Headache—Orlistat—type 2 diabetes mellitus	0.000121	0.000767	CcSEcCtD
Cyproheptadine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000121	0.000764	CcSEcCtD
Cyproheptadine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000121	0.000764	CcSEcCtD
Cyproheptadine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000119	0.000757	CcSEcCtD
Cyproheptadine—Carbamazepine—CYP1A2—type 2 diabetes mellitus	0.000119	0.0377	CrCbGaD
Cyproheptadine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000118	0.000747	CcSEcCtD
Cyproheptadine—Dizziness—Metformin—type 2 diabetes mellitus	0.000118	0.000747	CcSEcCtD
Cyproheptadine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000117	0.000741	CcSEcCtD
Cyproheptadine—Nausea—Valsartan—type 2 diabetes mellitus	0.000116	0.000736	CcSEcCtD
Cyproheptadine—Constipation—Ramipril—type 2 diabetes mellitus	0.000116	0.000735	CcSEcCtD
Cyproheptadine—Loxapine—HTR2C—type 2 diabetes mellitus	0.000115	0.0366	CrCbGaD
Cyproheptadine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000115	0.000729	CcSEcCtD
Cyproheptadine—Nausea—Orlistat—type 2 diabetes mellitus	0.000115	0.000728	CcSEcCtD
Cyproheptadine—Asthenia—Losartan—type 2 diabetes mellitus	0.000113	0.000719	CcSEcCtD
Cyproheptadine—Vomiting—Metformin—type 2 diabetes mellitus	0.000113	0.000718	CcSEcCtD
Cyproheptadine—Rash—Metformin—type 2 diabetes mellitus	0.000112	0.000712	CcSEcCtD
Cyproheptadine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000112	0.000711	CcSEcCtD
Cyproheptadine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000112	0.000708	CcSEcCtD
Cyproheptadine—Headache—Metformin—type 2 diabetes mellitus	0.000112	0.000707	CcSEcCtD
Cyproheptadine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000111	0.000704	CcSEcCtD
Cyproheptadine—Mianserin—CYP1A2—type 2 diabetes mellitus	0.000109	0.0348	CrCbGaD
Cyproheptadine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000108	0.000686	CcSEcCtD
Cyproheptadine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000108	0.000683	CcSEcCtD
Cyproheptadine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000107	0.000677	CcSEcCtD
Cyproheptadine—Rash—Irbesartan—type 2 diabetes mellitus	0.000106	0.000672	CcSEcCtD
Cyproheptadine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000106	0.000671	CcSEcCtD
Cyproheptadine—Nausea—Metformin—type 2 diabetes mellitus	0.000106	0.000671	CcSEcCtD
Cyproheptadine—Headache—Irbesartan—type 2 diabetes mellitus	0.000105	0.000667	CcSEcCtD
Cyproheptadine—Clozapine—ADRA2A—type 2 diabetes mellitus	0.000105	0.0334	CrCbGaD
Cyproheptadine—Dizziness—Losartan—type 2 diabetes mellitus	0.000105	0.000663	CcSEcCtD
Cyproheptadine—Nortriptyline—CYP2E1—type 2 diabetes mellitus	0.000103	0.0327	CrCbGaD
Cyproheptadine—Vomiting—Losartan—type 2 diabetes mellitus	0.000101	0.000637	CcSEcCtD
Cyproheptadine—Nausea—Irbesartan—type 2 diabetes mellitus	9.98e-05	0.000633	CcSEcCtD
Cyproheptadine—Rash—Losartan—type 2 diabetes mellitus	9.97e-05	0.000632	CcSEcCtD
Cyproheptadine—Dermatitis—Losartan—type 2 diabetes mellitus	9.96e-05	0.000632	CcSEcCtD
Cyproheptadine—Headache—Losartan—type 2 diabetes mellitus	9.91e-05	0.000628	CcSEcCtD
Cyproheptadine—Nortriptyline—CYP1A2—type 2 diabetes mellitus	9.76e-05	0.0311	CrCbGaD
Cyproheptadine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	9.75e-05	0.031	CrCbGaD
Cyproheptadine—Asthenia—Ramipril—type 2 diabetes mellitus	9.73e-05	0.000617	CcSEcCtD
Cyproheptadine—Clozapine—HTR2C—type 2 diabetes mellitus	9.65e-05	0.0307	CrCbGaD
Cyproheptadine—Nausea—Losartan—type 2 diabetes mellitus	9.39e-05	0.000596	CcSEcCtD
Cyproheptadine—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.28e-05	0.000588	CcSEcCtD
Cyproheptadine—Amitriptyline—HTR2C—type 2 diabetes mellitus	8.98e-05	0.0286	CrCbGaD
Cyproheptadine—Dizziness—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000568	CcSEcCtD
Cyproheptadine—Vomiting—Ramipril—type 2 diabetes mellitus	8.62e-05	0.000547	CcSEcCtD
Cyproheptadine—Rash—Ramipril—type 2 diabetes mellitus	8.55e-05	0.000542	CcSEcCtD
Cyproheptadine—Dermatitis—Ramipril—type 2 diabetes mellitus	8.54e-05	0.000542	CcSEcCtD
Cyproheptadine—Headache—Ramipril—type 2 diabetes mellitus	8.5e-05	0.000539	CcSEcCtD
Cyproheptadine—Nausea—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000511	CcSEcCtD
Cyproheptadine—Carbamazepine—CYP3A4—type 2 diabetes mellitus	7.85e-05	0.025	CrCbGaD
Cyproheptadine—Clozapine—CYP2E1—type 2 diabetes mellitus	7.66e-05	0.0244	CrCbGaD
Cyproheptadine—Clozapine—CYP1A2—type 2 diabetes mellitus	7.29e-05	0.0232	CrCbGaD
Cyproheptadine—Mianserin—CYP3A4—type 2 diabetes mellitus	7.23e-05	0.023	CrCbGaD
Cyproheptadine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	7.12e-05	0.0227	CrCbGaD
Cyproheptadine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	6.77e-05	0.0216	CrCbGaD
Cyproheptadine—Nortriptyline—CYP3A4—type 2 diabetes mellitus	6.46e-05	0.0206	CrCbGaD
Cyproheptadine—Nortriptyline—ALB—type 2 diabetes mellitus	5.64e-05	0.0179	CrCbGaD
Cyproheptadine—Clozapine—CYP3A4—type 2 diabetes mellitus	4.82e-05	0.0153	CrCbGaD
Cyproheptadine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	4.48e-05	0.0143	CrCbGaD
Cyproheptadine—Amitriptyline—ALB—type 2 diabetes mellitus	3.91e-05	0.0124	CrCbGaD
Cyproheptadine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.17e-06	4.5e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.17e-06	4.5e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	4.17e-06	4.5e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.17e-06	4.49e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.16e-06	4.49e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.16e-06	4.49e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.16e-06	4.49e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.15e-06	4.48e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.15e-06	4.48e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.15e-06	4.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.15e-06	4.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.15e-06	4.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.14e-06	4.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	4.14e-06	4.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	4.13e-06	4.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.11e-06	4.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.11e-06	4.43e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.1e-06	4.43e-05	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.1e-06	4.42e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.1e-06	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.1e-06	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.09e-06	4.41e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.09e-06	4.41e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.08e-06	4.4e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.08e-06	4.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.08e-06	4.4e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.08e-06	4.4e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.08e-06	4.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.06e-06	4.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.06e-06	4.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.06e-06	4.38e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.06e-06	4.38e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	4.05e-06	4.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	4.05e-06	4.37e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	4.04e-06	4.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.04e-06	4.35e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.04e-06	4.35e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.03e-06	4.34e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.02e-06	4.34e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	4.02e-06	4.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.02e-06	4.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.01e-06	4.32e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.01e-06	4.32e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	4e-06	4.32e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.97e-06	4.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.96e-06	4.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.95e-06	4.26e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.91e-06	4.22e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.91e-06	4.21e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.9e-06	4.21e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.89e-06	4.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.89e-06	4.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.88e-06	4.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.87e-06	4.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.85e-06	4.15e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.84e-06	4.14e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.84e-06	4.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.83e-06	4.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.82e-06	4.12e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.8e-06	4.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	3.79e-06	4.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.78e-06	4.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.74e-06	4.04e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.72e-06	4.02e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.71e-06	4e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.71e-06	4e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.7e-06	3.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.69e-06	3.98e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.68e-06	3.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.64e-06	3.93e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.64e-06	3.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	3.63e-06	3.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	3.63e-06	3.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.62e-06	3.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.61e-06	3.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.58e-06	3.86e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	3.55e-06	3.82e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.54e-06	3.82e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.54e-06	3.82e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—SRC—type 2 diabetes mellitus	3.54e-06	3.82e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.52e-06	3.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.52e-06	3.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.5e-06	3.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	3.49e-06	3.76e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.49e-06	3.76e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	3.48e-06	3.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	3.47e-06	3.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.47e-06	3.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	3.46e-06	3.73e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.45e-06	3.72e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.43e-06	3.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.43e-06	3.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.43e-06	3.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	3.43e-06	3.69e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.43e-06	3.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.41e-06	3.68e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.41e-06	3.68e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.4e-06	3.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.4e-06	3.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.37e-06	3.64e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.37e-06	3.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.37e-06	3.63e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.37e-06	3.63e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.37e-06	3.63e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.36e-06	3.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.36e-06	3.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.35e-06	3.62e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.35e-06	3.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.35e-06	3.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.34e-06	3.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.34e-06	3.6e-05	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—type 2 diabetes mellitus	3.34e-06	3.6e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.33e-06	3.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.33e-06	3.59e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	3.32e-06	3.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	3.32e-06	3.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.31e-06	3.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.31e-06	3.57e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.3e-06	3.56e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.26e-06	3.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.23e-06	3.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.2e-06	3.46e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.2e-06	3.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.19e-06	3.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.18e-06	3.43e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.16e-06	3.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.15e-06	3.39e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.15e-06	3.39e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.11e-06	3.35e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.11e-06	3.35e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.1e-06	3.35e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.06e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.06e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.05e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.05e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.04e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.04e-06	3.28e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.04e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.03e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.03e-06	3.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.02e-06	3.26e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.01e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3e-06	3.24e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.99e-06	3.23e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.99e-06	3.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.97e-06	3.21e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.93e-06	3.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.89e-06	3.11e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.88e-06	3.11e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.87e-06	3.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.86e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	2.86e-06	3.08e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.84e-06	3.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.83e-06	3.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.83e-06	3.05e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.83e-06	3.05e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.81e-06	3.03e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.8e-06	3.02e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.76e-06	2.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.74e-06	2.96e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.66e-06	2.87e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.64e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.62e-06	2.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.62e-06	2.83e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.62e-06	2.83e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.62e-06	2.82e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.61e-06	2.81e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.61e-06	2.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.6e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.6e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.59e-06	2.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.58e-06	2.79e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.58e-06	2.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.58e-06	2.78e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.58e-06	2.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.57e-06	2.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.57e-06	2.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.56e-06	2.76e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.55e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.55e-06	2.75e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.54e-06	2.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.53e-06	2.73e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.5e-06	2.69e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.47e-06	2.66e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.45e-06	2.65e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.45e-06	2.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.44e-06	2.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.43e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.43e-06	2.62e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.42e-06	2.61e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.42e-06	2.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.42e-06	2.61e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.41e-06	2.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.41e-06	2.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.38e-06	2.57e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	2.38e-06	2.57e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.38e-06	2.57e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.38e-06	2.56e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.37e-06	2.55e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.36e-06	2.55e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.34e-06	2.53e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.34e-06	2.52e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.33e-06	2.51e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.3e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.3e-06	2.48e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.28e-06	2.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.26e-06	2.44e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.26e-06	2.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.25e-06	2.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	2.24e-06	2.42e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.24e-06	2.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.22e-06	2.4e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.2e-06	2.38e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.2e-06	2.37e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.2e-06	2.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.19e-06	2.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.19e-06	2.36e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.18e-06	2.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.16e-06	2.33e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.06e-06	2.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.02e-06	2.18e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.02e-06	2.18e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.02e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.01e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.01e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.01e-06	2.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.99e-06	2.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.98e-06	2.14e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.98e-06	2.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.97e-06	2.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.97e-06	2.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.95e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.76e-06	1.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.76e-06	1.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.67e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.63e-06	1.76e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.62e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.55e-06	1.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.52e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.52e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.52e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.51e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.5e-06	1.61e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.43e-06	1.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.41e-06	1.52e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.4e-06	1.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.4e-06	1.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.39e-06	1.5e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.38e-06	1.49e-05	CbGpPWpGaD
